Compound	Per Tablet	Molecular Formula	Molecular Weight	Sequence / Structure	Purity
BPC-157	250 mcg	C₆₂H₉₈N₁₆O₂₂	1419.5 g/mol	GEPPPGKPADDAGLV	>99.1%
KPV	250 mcg	C₁₆H₃₀N₄O₄	342.43 g/mol	Lys-Pro-Val	>99.1%
Larazotide	250 mcg	C₃₄H₅₉N₉O₁₂	785.89 g/mol	Gly-Gly-Val-Leu-Val-Gln-Pro-Gly	>99.1%
Butyrate	250 mcg	C₄H₇NaO₂	110.09 g/mol	CH₃-CH₂-CH₂-COO⁻	>99.1%

The BPC-157 + KPV + Larazotide + Butyrate 250mcg × 60 research tablets are used in laboratory studies involving multi-compound GI modeling, peptide-tablet formulation behavior, dissolution analysis, BPC 157 pill format comparisons, KPV peptide evaluation, Larazotide acetate barrier-integrity simulation, and in vitro gut-environment compound characterization; related research areas include oral-format peptide stability, tablet uniformity, solubility workflows, and examination of multi-pathway interactions in controlled experimental systems. Related search topics include bpc 157 pills, bpc-157 pill form, bpc 157 peptide pills, bpc 157 pill vs injection, kpv peptide, kpv peptides, kpv side effects, larazotide acetate, larazotide research, gut barrier study models, and peptide blends for GI-related laboratory evaluation. Additional related products: BPC-157 10mg Amber Edition, TB-500 10mg Amber Edition, TB-500 + BPC-157 Wolverine Patches, GHK-Cu Glow Copper Patches, NAD+ 1000mg Amber Edition, Sermorelin 5mg Amber Edition, Tirzepatide 10mg & 30mg, Semaglutide 10mg, Retatrutide 10mg, and the GLP-1 Research Patch.